HomeInsightsPE

Raymed Labs Ltd PE Ratio

Raymed Labs Ltd PE Ratio

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Nov 11, 2024)

stocks purchased

0.0 K

Stocks Traded

(Nov 11, 2024)

Last Updated on: Dec 12, 2024

Image

Raymed Labs Ltd

NSE: RAYMEDLABS

PE

-

Last updated on: Dec 12, 2024

Key Highlights

  • The P/E Ratio of Raymed Labs Ltd is 0 as of 12 Dec 10:23 AM .
  • The P/E Ratio of Raymed Labs Ltd changed from 0 on March 2019 to 0 on March 2024 . This represents a CAGR of 0.0% over 6 years.
  • The Latest Trading Price of Raymed Labs Ltd is ₹ 2.75 as of 11 Nov 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.5. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Raymed Labs Ltd

No data available

Company Fundamentals for Raymed Labs Ltd

No data available

Image

Raymed Labs Ltd

NSE: RAYMEDLABS

Share Price

₹ 2.75

0.00 (0.00%)

stock direction

Last updated on: Nov 11, 2024

Market Price of Raymed Labs Ltd

1M

1Y

3Y

5Y

Monitoring Raymed Labs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
11 Nov 20242.75
21 Oct 20242.75
23 Sep 20242.62
16 Sep 20242.62
09 Sep 20242.62
29 Jul 20242.5
08 Jul 20242.5
10 Jun 20242.39
03 Jun 20242.28
27 May 20242.28

BlinkX Score for Raymed Labs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Raymed Labs Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Raymed Labs Ltd01
Sun Pharmaceuticals Industries Ltd384,35,407
Divis Laboratories Ltd851,57,489
Cipla Ltd251,17,443
Torrent Pharmaceuticals Ltd651,14,197
Mankind Pharma Ltd491,05,098

Key Valuation Metric of Raymed Labs Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Raymed Labs Ltd

No data available

* All values are in crore

Historical Revenue of Raymed Labs Ltd

No data available

* All values are in crore

Historical EBITDA of Raymed Labs Ltd

No data available

* All values are in crore

Historical Net Profit of Raymed Labs Ltd

No data available

* All values are in crore

Historical Dividend Payout of Raymed Labs Ltd

No data available

* All values are in %

About Raymed Labs Ltd

  • Raymed Labs Ltd was established in the year 1994 as a pharmaceutical company with emphasis on injectables with state of the art manufacturing facilities on Dehradun Road, Saharanpur, UP. The Company embarked on a new and exciting phase of its growth journey.
  • As a widely operational pharmaceutical company, it proved excellence in the competitive ophthalmology industry with its robust marketing infrastructure across the geographies. Raymed created an integrated multi-technology capability to manufacture all types of formulations with innovative and advanced technologies focusing into Preservative free Ophthalmic dosage specially for Conjunctivitis and Glaucoma Patient care, Various other formulations have been converted from suspension to solution which helps in the effective absorption, penetration and better patience compliance.

Raymed Labs Ltd News Hub

News

Raymed Labs to convene AGM

Raymed Labs announced that the Annual General Meeting (AGM) of the company will be held on...

Read more

2024-08-17 00:00:00

News

Raymed Labs to convene AGM

Raymed Labs announced that the Annual General Meeting (AGM) of the company will be held on...

Read more

2024-08-16 00:00:00

News

Raymed Labs schedules AGM

Raymed Labs announced that the Annual General Meeting (AGM) of the company will be held on...

Read more

2024-08-16 00:00:00

News

Raymed Labs reports standalone net loss of Rs 0.02 crore in the June 2024 quarter

Net Loss of Raymed Labs reported to Rs 0.02 crore in the quarter ended June 2024 as agains...

Read more

2024-08-13 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Raymed Labs Ltd

What is the current PE Ratio of Raymed Labs Ltd?

The Current PE Ratio of Raymed Labs Ltd is 0.0 as on 12 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 12 Dec 2024.

What was the PE Ratio of Raymed Labs Ltd last year?

The PE Ratio of Raymed Labs Ltd was 0.0 last year, now the PE ratio is 0.0, showing a year-on-year growth of -%.

What does the PE Ratio of Raymed Labs Ltd indicate about its stock?

The PE Ratio of Raymed Labs Ltd is 0.0. This ratio indicates that investors are willing to pay 0.0 times the earnings per share for each share of Raymed Labs Ltd.

What is the PE Ratio Growth of Raymed Labs Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Raymed Labs Ltd grew by -% whereas, the EPS ratio grew by -0.0.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions